$KYMR
Kymera Therapeutics, Inc.

2023 Q4 Form 10-Q Financial Statement

#000095017023057743 Filed on November 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $47.89M $4.728M
YoY Change 196.7% -50.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $14.23M $14.12M
YoY Change 22.27% 33.76%
% of Gross Profit
Research & Development $52.97M $48.12M
YoY Change 22.81% 9.66%
% of Gross Profit
Depreciation & Amortization $865.0K $900.0K
YoY Change 5.75% 112400.0%
% of Gross Profit
Operating Expenses $67.20M $62.24M
YoY Change 22.69% 14.34%
Operating Profit -$57.51M
YoY Change 28.13%
Interest Expense $4.944M $4.640M
YoY Change 31.31% 146.81%
% of Operating Profit
Other Income/Expense, Net $4.642M
YoY Change 146.91%
Pretax Income -$14.37M -$52.87M
YoY Change -58.79% 22.95%
Income Tax $100.0K
% Of Pretax Income
Net Earnings -$14.37M -$52.87M
YoY Change -58.79% 22.94%
Net Earnings / Revenue -30.01% -1118.17%
Basic Earnings Per Share -$0.90
Diluted Earnings Per Share -$0.25 -$0.90
COMMON SHARES
Basic Shares Outstanding 55.49M 55.41M
Diluted Shares Outstanding 58.42M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $374.9M $357.8M
YoY Change -7.93% -25.75%
Cash & Equivalents $110.0M $81.05M
Short-Term Investments $264.9M $276.8M
Other Short-Term Assets $11.67M $14.10M
YoY Change 20.19% 52.73%
Inventory
Prepaid Expenses
Receivables $15.00M $3.800M
Other Receivables $0.00 $0.00
Total Short-Term Assets $405.3M $375.7M
YoY Change -3.36% -23.95%
LONG-TERM ASSETS
Property, Plant & Equipment $48.13M $36.15M
YoY Change 260.99% 187.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $61.43M $77.00M
YoY Change -59.67% -32.28%
Other Assets $2.118M $2.802M
YoY Change -29.8% -7.1%
Total Long-Term Assets $170.4M $176.7M
YoY Change -7.23% 22.31%
TOTAL ASSETS
Total Short-Term Assets $405.3M $375.7M
Total Long-Term Assets $170.4M $176.7M
Total Assets $575.8M $552.4M
YoY Change -4.54% -13.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.075M $4.978M
YoY Change 63.21% -21.32%
Accrued Expenses $33.86M $26.38M
YoY Change 23.13% 6.85%
Deferred Revenue $37.88M $27.35M
YoY Change 7.44% -50.96%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.277M $1.000M
YoY Change -9.3% -9.34%
Total Short-Term Liabilities $85.69M $63.17M
YoY Change 20.11% -30.68%
LONG-TERM LIABILITIES
Long-Term Debt $1.301M $600.0K
YoY Change 4.41% -13.04%
Other Long-Term Liabilities $0.00 $8.000K
YoY Change -100.0% -96.88%
Total Long-Term Liabilities $0.00 $8.000K
YoY Change -100.0% -96.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $85.69M $63.17M
Total Long-Term Liabilities $0.00 $8.000K
Total Liabilities $180.8M $156.8M
YoY Change 60.01% 24.89%
SHAREHOLDERS EQUITY
Retained Earnings -$530.8M -$516.4M
YoY Change 38.3% 48.01%
Common Stock $926.3M $914.4M
YoY Change 5.39% 5.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $395.0M $395.5M
YoY Change
Total Liabilities & Shareholders Equity $575.8M $552.4M
YoY Change -4.54% -13.48%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$14.37M -$52.87M
YoY Change -58.79% 22.94%
Depreciation, Depletion And Amortization $865.0K $900.0K
YoY Change 5.75% 112400.0%
Cash From Operating Activities $8.074M -$31.70M
YoY Change -120.42% -7.5%
INVESTING ACTIVITIES
Capital Expenditures $11.58M $8.100M
YoY Change 3004.56% -750.08%
Acquisitions
YoY Change
Other Investing Activities $30.57M $68.60M
YoY Change -162.01% -289.32%
Cash From Investing Activities $18.99M $60.50M
YoY Change -138.23% -261.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.892M -200.0K
YoY Change -3.12% -100.13%
NET CHANGE
Cash From Operating Activities 8.074M -31.70M
Cash From Investing Activities 18.99M 60.50M
Cash From Financing Activities 1.892M -200.0K
Net Change In Cash 28.95M 28.60M
YoY Change -133.18% -63.68%
FREE CASH FLOW
Cash From Operating Activities $8.074M -$31.70M
Capital Expenditures $11.58M $8.100M
Free Cash Flow -$3.506M -$39.80M
YoY Change -91.22% 20.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001815442
CY2023Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#RelatedPartyMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#RelatedPartyMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#RelatedPartyMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39460
dei Entity Registrant Name
EntityRegistrantName
KYMERA THERAPEUTICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2992166
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Arsenal Yards Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
857
dei Local Phone Number
LocalPhoneNumber
285-5300
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
16421000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
28000000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
76605000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12146000
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
643000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1246000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
KYMR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55487373
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81051000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68395000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
276774000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
338771000
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3778000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2537000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14091000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9713000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
375694000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
419416000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
76988000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
152328000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36145000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13334000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
54955000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8909000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2802000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3017000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5794000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6130000
CY2023Q3 us-gaap Assets
Assets
552378000
CY2022Q4 us-gaap Assets
Assets
603134000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4978000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4335000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26383000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27502000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
27352000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35260000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2585000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2535000
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1010000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1408000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
858000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
303000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
63166000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71343000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
248000
CY2023Q3 us-gaap Liabilities
Liabilities
156843000
CY2022Q4 us-gaap Liabilities
Liabilities
112983000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55450239
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55450239
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55039380
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55039380
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
6000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
914363000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
878884000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-516384000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-383790000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2450000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4949000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
395535000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
490151000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
552378000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
603134000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4728000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9551000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30707000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30687000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48117000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43877000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
136111000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
121115000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14120000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10556000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40814000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32198000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
62237000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
54433000
us-gaap Operating Expenses
OperatingExpenses
176925000
us-gaap Operating Expenses
OperatingExpenses
153313000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-57509000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-44882000
us-gaap Operating Income Loss
OperatingIncomeLoss
-146218000
us-gaap Operating Income Loss
OperatingIncomeLoss
-122626000
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4683000
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1916000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
13768000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2800000
CY2023Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
41000
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
36000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
144000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
117000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4642000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1880000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13624000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2683000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-52867000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-43002000
us-gaap Net Income Loss
NetIncomeLoss
-132594000
us-gaap Net Income Loss
NetIncomeLoss
-119943000
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1185000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1930000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2499000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-5253000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51682000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44932000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-130095000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-125196000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-52867000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-43002000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-132594000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-119943000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.9
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.9
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.28
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58421859
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58421859
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54535514
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54535514
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58312813
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58312813
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52600103
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52600103
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
397951000
CY2022Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
174000
CY2022Q3 kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
149826000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
964000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9076000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1930000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-43002000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
512885000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
435428000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
135000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11654000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1185000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-52867000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
395535000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
459638000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
174000
kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
149826000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1790000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
256000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26571000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5253000
us-gaap Net Income Loss
NetIncomeLoss
-119943000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
512885000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
490151000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2297000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
962000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32220000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2499000
us-gaap Net Income Loss
NetIncomeLoss
-132594000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
395535000
us-gaap Profit Loss
ProfitLoss
-132594000
us-gaap Profit Loss
ProfitLoss
-119943000
us-gaap Share Based Compensation
ShareBasedCompensation
32220000
us-gaap Share Based Compensation
ShareBasedCompensation
26571000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2674000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2159000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
-3960000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
1794000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4378000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
512000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
1241000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
2747000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
507000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2321000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3613000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1677000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-19487000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-24172000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-2787000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-378000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
15675000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-738000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-539000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
337000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-110871000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-113549000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22855000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2463000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
143647000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
298736000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
287436000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
371384000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
120934000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
70185000
kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants At Private Placement Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
0
kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants At Private Placement Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
149825000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2297000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1790000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
962000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
256000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1001000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
825000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2258000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
151046000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12321000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107682000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
74524000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54092000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86845000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161774000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
48833000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Interest Paid Net
InterestPaidNet
115000
us-gaap Interest Paid Net
InterestPaidNet
124000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
2762000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
340000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
0
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
87000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81051000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155658000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
5794000
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
6116000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86845000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161774000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-516400000
CY2023Q3 us-gaap Investments And Cash
InvestmentsAndCash
434800000
CY2023Q3 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2022Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2023Q3 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2022Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2023Q3 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2022Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2023Q3 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
356211000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2450000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
353762000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
496044000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
53000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4998000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
491099000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
106
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
231500000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
149
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
330900000
kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
56
CY2023Q3 kymr Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
114800000
CY2022 kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
36
CY2022Q4 kymr Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
115000000
kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
125
CY2023Q3 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
276800000
kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
39
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
77000000
CY2022 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
118
CY2022Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
338800000
CY2022 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
81
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
152300000
us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
CY2023Q3 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
CY2022Q4 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
kymr Cost Reimbursement Payment Received
CostReimbursementPaymentReceived
10000000
CY2023Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3800000
kymr Remaining Research Term Of Collaboration
RemainingResearchTermOfCollaboration
P2Y3M18D
CY2022Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
2537000
kymr Contract With Customer Asset Net Additions
ContractWithCustomerAssetNetAdditions
21199000
kymr Contract With Customer Asset Net Deductions
ContractWithCustomerAssetNetDeductions
19958000
CY2023Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
3778000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
63260000
kymr Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
11220000
kymr Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
-30707000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
43773000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
45694000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20227000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9549000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6893000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36145000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13334000
CY2023Q3 us-gaap Depreciation
Depreciation
900000
CY2022Q3 us-gaap Depreciation
Depreciation
800000
us-gaap Depreciation
Depreciation
2700000
us-gaap Depreciation
Depreciation
2200000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
400000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
300000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1100000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
900000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2521000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
524000
us-gaap Operating Lease Cost
OperatingLeaseCost
7562000
us-gaap Operating Lease Cost
OperatingLeaseCost
1571000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
369000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
297000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1108000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
855000
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
37000
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
39000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
133000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
124000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
273000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
297000
us-gaap Variable Lease Cost
VariableLeaseCost
712000
us-gaap Variable Lease Cost
VariableLeaseCost
870000
CY2023Q3 us-gaap Lease Cost
LeaseCost
3200000
CY2022Q3 us-gaap Lease Cost
LeaseCost
1157000
us-gaap Lease Cost
LeaseCost
9515000
us-gaap Lease Cost
LeaseCost
3420000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
1989000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
1931000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1001000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
833000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
133000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
124000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1653000
CY2023Q3 kymr Undiscounted Future Lease Payments
UndiscountedFutureLeasePayments
7000000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y5M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M2D
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M17D
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M21D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0878
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0848
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0873
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6285000
CY2023Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
328000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
11496000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
839000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12142000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
402000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12506000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
133000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12881000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
100000
CY2023Q3 kymr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
85143000
CY2023Q3 kymr Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
0
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
127883000
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1802000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
48693000
CY2023Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
149000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
79190000
CY2023Q3 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
11369000
CY2022Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
16975000
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8057000
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8149000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3644000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1971000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3313000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
407000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26383000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27502000
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y29D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M9D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M2D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.63
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0414
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0301
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0406
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0195
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11655000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9076000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32220000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26571000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-52867000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-43002000
us-gaap Net Income Loss
NetIncomeLoss
-132594000
us-gaap Net Income Loss
NetIncomeLoss
-119943000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58421859
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58421859
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54535514
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54535514
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58312813
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58312813
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52600103
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52600103
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.9
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.9
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.28
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8837606
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7291922
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-057743-index-headers.html Edgar Link pending
0000950170-23-057743-index.html Edgar Link pending
0000950170-23-057743.txt Edgar Link pending
0000950170-23-057743-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kymr-20230930.htm Edgar Link pending
kymr-20230930.xsd Edgar Link pending
kymr-ex31_1.htm Edgar Link pending
kymr-ex31_2.htm Edgar Link pending
kymr-ex32_1.htm Edgar Link pending
kymr-20230930_cal.xml Edgar Link unprocessable
kymr-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
kymr-20230930_lab.xml Edgar Link unprocessable
kymr-20230930_pre.xml Edgar Link unprocessable
kymr-20230930_htm.xml Edgar Link completed
kymr-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending